HomeOPK • NASDAQ
add
OPKO Health Inc
Previous close
$1.56
Day range
$1.55 - $1.61
Year range
$0.85 - $1.75
Market cap
1.08B USD
Avg Volume
3.92M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 173.63M | -2.78% |
Operating expense | 118.64M | 26.51% |
Net income | 24.89M | 129.47% |
Net profit margin | 14.33 | 130.30% |
Earnings per share | — | — |
EBITDA | -83.11M | -111.97% |
Effective tax rate | 48.59% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 400.08M | 188.61% |
Total assets | 2.26B | 9.70% |
Total liabilities | 852.69M | 39.30% |
Total equity | 1.40B | — |
Shares outstanding | 682.48M | — |
Price to book | 0.76 | — |
Return on assets | -12.66% | — |
Return on capital | -14.98% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 24.89M | 129.47% |
Cash from operations | -77.08M | -332.80% |
Cash from investing | 247.78M | 7,036.84% |
Cash from financing | 206.14M | 9,692.87% |
Net change in cash | 379.49M | 1,143.70% |
Free cash flow | 29.19M | -53.06% |
About
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK". Wikipedia
Founded
1991
Headquarters
Website
Employees
3,930
